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We appreciate the interest of Dr. Jao and colleagues in our study
“Low-Gradient Aortic Valve Stenosis: Myocardial Fibrosis and Its
Influence on Function and Outcome” (1). We fully agree that
angiotensin-converting enzyme (ACE) inhibitors have an impact
on hemodynamics and probably also on prognosis in patients with
aortic stenosis. Thus, we want to provide the information that both
ACE inhibitors and aldosterone antagonists were homogenously
distributed within the different groups.
However, the aim of our study was not to analyze the impact of
pharmacological therapy on hemodynamics and prognosis in
patients with aortic stenosis, which can only be done in larger
prospective cohort studies. Rather, we tried to describe in detail the
typical morphology, function, and hemodynamics of patients with
a low-gradient aortic stenosis. In this respect, we analyzed the
systemic vascular resistance and the valvuloarterial impedance,
which should both reflect the impact of an ACE inhibitor therapy
and other blood pressure–lowering medications.
In addition, we agree, due to our own experience, that patients
with aortic stenosis can be treated with ACE inhibitors and that
this pharmacological therapy can both prevent progression of the
disease in earlier stages and reduces cardio vascular events in later
stages (2,3). However, at the right time, there has to be a causaltherapy like aortic valve replacement to avoid the progress towards
myocardial fibrosis and to ameliorate long-term prognosis and
cardiac remodeling.
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